African Pharmaceutical Review
.
African Pharmaceutical Review
.
Trending
US FDA approves key antibiotic combination for treatment against resistant strains
Eli Lilly, Eva Pharma partner to enhance access to key immunomodulatory drug across Africa.
Lonza Secures Long-Term Agreement to Supply Critical Cell Therapy for Sickle Cell Treatment
Write For Us
|
Advertise with us
Sign In
Subscribe
Home
News
Articles
Interviews
Videos
Webinars
Publications
Whitepapers/Application Notes
Events
Podcasts
Featured Companies
QA/QC
R&D
Supply Chain
Digitalization
Analytical Techniques
Manufacturing
Regulatory affairs
Biopharma
Drug delivery
Formulation
Subscribe
Sign In
News
Articles
Interviews
Videos
Webinars
Publications
Whitepapers/Application Notes
Events
Podcasts
R&D
View All
US FDA approves key antibiotic combination for treatment against resistant strains
by
APR Team
10 Feb, 2025
1 Mins Read
National Cancer Institute Awards $2.5 Million Grant to Enhance Leukemia and Lymphoma Testing in Kenya
by
APR Team
29 Jan, 2025
2 Mins Read
Injectable drug shows 99.9% efficacy in HIV prevention
by
APR Team
28 Nov, 2024
1 Mins Read
AstraZeneca’s first in class therapy shows efficacy in metastatic prostate cancer
by
APR Team
26 Nov, 2024
1 Mins Read
FDA accepts for review GSK’s new multiple myeloma therapy
by
APR Team
26 Nov, 2024
1 Mins Read
Drug shows reduced risk of progression to type 2 diabetes in pre-diabetics
by
APR Team
15 Nov, 2024
1 Mins Read
Selumetinib shows efficacy in adult patients with neurofibromatosis
by
APR Team
13 Nov, 2024
1 Mins Read
AbbVie’s emraclidine fails to demonstrate efficacy in management of schizophrenia
by
APR Team
12 Nov, 2024
1 Mins Read
Anti-asthmatic therapy shows efficacy in treatment of chronic rhinosinusitis with nasal polyps
by
APR Team
09 Nov, 2024
1 Mins Read
Regeneron’s dupilumab has achieved approval in Europe as the first treatment approved for children with eosinophilic esophagitis
by
APR Team
06 Nov, 2024
1 Mins Read
GSK acquires new investigational therapy targeted for lupus treatment
by
APR Team
30 Oct, 2024
1 Mins Read
AstraZeneca’s brand of benralizumab gains approval in Europe
by
APR Team
29 Oct, 2024
1 Mins Read
Oral semaglutide shows reduction in risk of major adverse cardiovascular events in diabetic patients
by
APR Team
22 Oct, 2024
1 Mins Read
First once-daily subcutaneous prophylactic treatment for hemophilia recommended for European approval
by
APR Team
20 Oct, 2024
1 Mins Read
Innovative subcutaneous combination therapy receives approval for Parkinson's disease
by
APR Team
18 Oct, 2024
1 Mins Read
GSK’s first-in-class antibiotic with new mechanism of action approved for priority review
by
APR Team
16 Oct, 2024
1 Mins Read
AstraZeneca to pay up to $1.92 billion for potentially new lipid lowering molecule
by
APR Team
07 Oct, 2024
1 Mins Read
FDA approves drug with new pharmacological approach to schizophrenia treatment
by
APR Team
27 Sep, 2024
1 Mins Read
AstraZeneca’s Fasenra set to be approved for eosinophilic granulomatosis treatment
by
APR Team
23 Sep, 2024
1 Mins Read
Novo Nordisk’s Wegovy® expects label update to include benefits in improving heart failure symptoms and physical function.
by
APR Team
20 Sep, 2024
1 Mins Read
Roche’s Xofluza reduces transmission of flu viruses, global trial shows
by
APR Team
19 Sep, 2024
1 Mins Read
Bristol Myers Squibb’s Zeposia exhibits sustained safety and efficacy in Multiple sclerosis
by
APR Team
18 Sep, 2024
2 Mins Read
Novartis Kisqali® has received FDA approval to lower recurrence risk in patients with HR+/HER2-early breast cancer.
by
APR Team
17 Sep, 2024
2 Mins Read
Research shows 2-drug HIV regimen with comparable efficacy to 3-drug regimen
by
Bevin Likuyani
25 Jul, 2024
1 Mins Read
Disrupting and accelerating drug discovery for faster and more accurate lead identification
by
Bevin Likuyani
23 Jul, 2024
0 Mins Read
Get Our Latest News & Update
Submit Now
Follow Us: